Veterinary Medicines

Unisol 5 mg/ml oral solution for piglets

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Unisol 5 mg/ml oral solution for piglets
Lanflox 0,5% belsőleges oldat malacok részére A.U.V.
Active substance:
  • Enrofloxacin
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Container Material: High density polyethylene bottles Container Closure: Polypropylene screw cap Container Colour: White Container Volume: 250 ml Dosing Device: Polypropylene/polyethylene/stainless steel pump dispensing 1 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetpharma Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 2575 /X/09 MgSzH ÁTI
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0216/001
Concerned member states:
  • Hungary
  • Italy
  • Poland
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."